Fernando Correa
Executive Director Kodiak Sciences
Fernando Corrêa is an Executive Director at Kodiak Sciences, where he leads Discovery Medicine efforts focused on advancing innovative therapies for retinal diseases. During nearly a decade at Kodiak, he has held multiple scientific leadership roles and played a key role in translating discovery research into clinical development. A biochemist by training, Fernando brings approximately 20 years of experience in protein science and drug discovery, with expertise spanning biochemistry, molecular biology, and biophysics. He is also a dedicated mentor and collaborative leader with a strong track record of guiding multidisciplinary teams.
Seminars
Wednesday 20th January 2027
From Molecular Design to Clinical Durability: Extending Ocular Half- Life with the Antibody Biopolymer Conjugate (ABC) Platform
9:00 am
- Explore how the ABC Platform increases molecular size and extends ocular residence time
- Review clinical evidence linking tarcocimab’s approximately 20-day ocular halflife to durable disease control and longer dosing intervals
- Discover how the Antibody Biopolymer Conjugate Drug (ABCD) Platform extends ABC into a modular system for the tailored delivery of diverse drug cargos and durable multi-mechanism therapies
